Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease
This study describes a class of small molecule compounds that promote ABCA1-dependent cholesterol efflux via a non-transcriptional mechanism, the identification of the molecular target by a chemical biology approach, and the potential of these agents for the treatment of chronic kidney diseases and...
Guardado en:
Autores principales: | Matthew B. Wright, Javier Varona Santos, Christian Kemmer, Cyrille Maugeais, Jean-Philippe Carralot, Stephan Roever, Judith Molina, G. Michelle Ducasa, Alla Mitrofanova, Alexis Sloan, Anis Ahmad, Christopher Pedigo, Mengyuan Ge, Jeffrey Pressly, Laura Barisoni, Armando Mendez, Jacopo Sgrignani, Andrea Cavalli, Sandra Merscher, Marco Prunotto, Alessia Fornoni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5e4a9ac05ca4c609714e39b90c7084e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
por: A. Mitrofanova, et al.
Publicado: (2019) -
Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma
por: Cheng-Wei Chou, et al.
Publicado: (2021) -
Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis
por: Peir-Haur Hung, et al.
Publicado: (2021) -
Glucose Metabolism in Acute Kidney Injury and Kidney Repair
por: Lu Wen, et al.
Publicado: (2021) - Kidney forum